A review of new science, in plain language

Science Advances  ·  16 October 2026  ·  From issue 53

Immune biomarkers of response and resistance to ipilimumab and nivolumab in metastatic castration-resistant prostate cancer

A low dose immune drug combo matched higher doses but caused fewer side effects in prostate cancer.

Apostolia M. Tsimberidou, Christopher R. Cabanski et al.

Integrity screen: passed (3 checks) Checked 20 October 2026. Read the source

The plain-language reading of this paper is in the full issue, for subscribers.

Read the full issue

Get it free, every two days

Five papers free every issue, about 15 emails a month. No spam. Leave in one click.

Also in issue 53 15 papers
More from Science Advances